Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan;13(1):13-27.
doi: 10.1038/nrgastro.2015.186. Epub 2015 Dec 2.

Immunopathogenesis of IBD: current state of the art

Heitor S P de Souza  1 , Claudio Fiocchi  2
Affiliations
Review

Immunopathogenesis of IBD: current state of the art

Heitor S P de Souza et al. Nat Rev Gastroenterol Hepatol. 2016 Jan.

Abstract

IBD is a chronic inflammatory condition of the gastrointestinal tract encompassing two main clinical entities: Crohn's disease and ulcerative colitis. Although Crohn's disease and ulcerative colitis have historically been studied together because they share common features (such as symptoms, structural damage and therapy), it is now clear that they represent two distinct pathophysiological entities. Both Crohn's disease and ulcerative colitis are associated with multiple pathogenic factors including environmental changes, an array of susceptibility gene variants, a qualitatively and quantitatively abnormal gut microbiota and a broadly dysregulated immune response. In spite of this realization and the identification of seemingly pertinent environmental, genetic, microbial and immune factors, a full understanding of IBD pathogenesis is still out of reach and, consequently, treatment is far from optimal. An important reason for this unsatisfactory situation is the currently limited comprehension of what are the truly relevant components of IBD immunopathogenesis. This article will comprehensively review current knowledge of the classic immune components and will expand the concept of IBD immunopathogenesis to include various cells, mediators and pathways that have not been traditionally associated with disease mechanisms, but that profoundly affect the overall intestinal inflammatory process.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Aliment Pharmacol Ther. 2011 Apr;33(8):940-5 - PubMed
    1. Nat Rev Gastroenterol Hepatol. 2011 Mar;8(3):152-68 - PubMed
    1. Gastroenterology. 1995 May;108(5):1434-44 - PubMed
    1. Nat Rev Gastroenterol Hepatol. 2015 May;12(5):271-83 - PubMed
    1. Gastroenterology. 2006 Jul;131(1):117-29 - PubMed

MeSH terms